Volume 7 Number 9

Editorial
160
How to remain focussed in a globalised world

EuroIntervention 2012;7:1009-1010

161
It’s time to say goodbye... (to the first-generation drug-eluting stent era)

EuroIntervention 2012;7:1011-1013

162
Repetita iuvant (repeating helps): why another paper on a new stent is important

EuroIntervention 2012;7:1014-1017

EAPCI column
163
Young interventionalists

EuroIntervention 2012;7:1019-1020

Clinical research
164
Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial

EuroIntervention 2012;7:1021-1029

165
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents

EuroIntervention 2012;7:1030-1042

166
Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis

EuroIntervention 2012;7:1043-1050 publish online ahead of print July 2011

167
A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients

EuroIntervention 2012;7:1051-1059

168
Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2012;7:1060-1061 publish onlinea ahead of print September 2011

169
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry

EuroIntervention 2012;7:1062-1068

170
Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome

EuroIntervention 2012;7:1069-1076 publish online ahead of print August 2011

171
Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter

EuroIntervention 2012;7:1077-1080 publish online ahead of print September 2011

172
Brain tumours among interventional cardiologists: a cause for alarm?

EuroIntervention 2012;7:1081-1086

Experimental research
173
Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation

EuroIntervention 2012;7:1087-1094 publish online ahead of print November 2011

Expert review
174
Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies

EuroIntervention 2012;7:1095-1102 publish online ahead of print September 2011

175
Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base

EuroIntervention 2012;7:1103-1110 publish online ahead of print September 2011

How should I treat?
176
How should I treat an iatrogenic aortic dissection as a complication of complex PCI?

EuroIntervention 2012;7:1111-1117

Tools & Techniques
177
Tools & Techniques: Above the knee angioplasty by transradial access

EuroIntervention 2012;7:1118-1119

178
Tools & Techniques: Below the knee interventions

EuroIntervention 2012;7:1120-1123

Image in cardiology
179
Catheter-induced coronary dissection during optical coherence tomography investigation

EuroIntervention 2012;7:1124-1125

Volume 7 Number 9 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Cordis, a Johnson & Johnson company
  • Edwards Lifesciences
  • Hexacath
  • Medtronic

Online ISSN 1969-6213 - Print ISSN 1774-024X